Abstract:The prognosis of esophageal cancer is not only affected by TNM stage but also by the level of serum vascular endothelial growth factor (S-VEGF). This study was to investigate the effect of concurrent chemoradiotherapy on S-VEGF in esophageal squamous cell carcinoma (ESCC), and to explore the correlation of S-VEGF to the prognosis of ESCC.Serum samples were obtained from ESCC patients, treated with concurrent chemoradiotherapy in Cancer Center of Sun Yat-sen University from Dec. 2002 to May 2004, before treatment and 1 month after treatment. The serum samples from sex- and age-matched healthy donors were used as controls. Two courses of chemotherapy, comprised of cisplatin and 5-fluorouracil, were given during radiotherapy at 4-week intervals. S-VEGF level was measured by ELISA. The changes of S-VEGF level before and after treatment were observed, and its correlation to progress-freely survival rate of ESCC patients was analyzed.S-VEGF level was significantly higher in ESCC patients before and 1 month after treatment than in healthy controls [(516.27+/-67.89) ng/L and (347.19+/-35.42) ng/L vs. (294.20+/-23.40) ng/L, P<0.01, P=0.002]; concurrent chemoradiotherapy significantly reduced S-VEGF level (P<0.01). S-VEGF level before treatment was significantly lower in the patients achieved complete remission than in those achieved partial remission or had progressive disease [(345.82+/-76.29) ng/L vs. (669.37+/-99.04) ng/L, P =0.020]. The 1-year progress-freely survival rate was 0 in the patients with S-VEGF level of > 516.27 ng/L before treatment and >347.19 ng/L after treatment, 17% in the patients with S-VEGF level of > 516.27 ng/L and <347.19 ng/L, respectively, 57% in the patients with S-VEGF level of < 516.27 ng/L and >347.19 ng/L, respectively, and 72% in the patients with S-VEGF level of < 516.27 ng/L and <347.19 ng/L, respectively (P= 0.005).S-VEGF level is higher in ESCC patients than in healthy control. Concurrent chemoradiotherapy could reduce S-VEGF level in ESCC. The changes of S-VEGF level before and after treatment may provide prognostic information for ESCC patients.

Correlation Analysis Between the VEGF Expression and Chemotherapeutic Efficacy in Patients with Oral Squamous Cell Carcinoma

Expression of VEGF and Its Correlation with Prognosis of Small Cell Lung Cancer

Effect of transcatheter arterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor in cervical squamous cell carcinoma

Correlation analysis of the chemotherapeutic effect of pingyangmycin on 43 patients with oral squamous cell carcinoma

Expression of VEGF-C and Its Correlation with Cervical Lymph Nodes Metastasis of Oral Cancers

Expression of vascular endothelial growth factor and its correlation with clinicopathologi-cal characteristics in esophageal squamous cell cancer

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Cyclooxygenase-2 Expression and Its Correlation with Vascular Endothelial Growth Factor in Oral Squamous Cell Carcinoma

[Expression of Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-3 and Nm23-H1 in Oral Squamous Cell Carcinoma].

Relationship Between Preoperative Serum TSH Levels and Expression of VEGF in Differentiated Thyroid Carcinoma

The Correlation Between Expression of Vascular Endothelial Growth Factor and Invasiveness and Metastasis of Gastric Carcinoma

Peripheral Blood Dendritic Cells and Vascular Endothelial Growth Factor in Oral Squamous Cell Carcinoma: Correlation Analysis and in Vitro Study

Vascular endothelial growth factor-C,lymphangiogenesis,angiogenesis and lymphatic metastasis of oral cancer

Correlation between Vascular Endothelial Growth Factor Expression and Prognosis of Esophageal Cancer: A Meta-Analysis

The Relationship Between VEGF-C, flt-4mRNA Expression and Lymphangiogenesis of Oral Squamous Cell Carcinoma

Clinical significance of expression of vascular endothelial growth factor in epithelial ovarian cancer

Prognostic significance of VEGF immunohistochemical expression in oral cancer: a meta-analysis of the literature

Expression of vascular endothelial growth factor and proliferation cell nuclear antigen in esophageal carcinoma treated by radiotherapy

Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases]

Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma

Survival analysis: expression of vascular endothelial growth factor affection